Target intelligence / Profile preview

Pulmonary alveolar epithelium

Molecular classification
Other
01

Overview

The pulmonary alveolar epithelium is a specialized thin epithelial layer lining the surface of pulmonary alveoli in the lung. It consists mainly of two cell types: type I alveolar epithelial cells (type I pneumocytes), which are squamous and cover about 95% of the alveolar surface participating directly in gas exchange, and type II alveolar epithelial cells (type II pneumocytes), which secrete pulmonary surfactant and act as progenitors for type I cells, contributing to repair and regeneration of alveoli after injury. The alveolar epithelium forms a critical part of the air–blood barrier, serving as both a site of rapid oxygen and carbon dioxide exchange and as a defensive interface protecting the lung from environmental insults. It also includes alveolar macrophages involved in immune surveillance and debris clearance[1][2][3][6]. Key points relevant to your query: - "Pulmonary alveolar epithelium" is a cellular structure or tissue layer, not a single molecule or traditional therapeutic target such as a receptor, enzyme, or transporter[1][2][3][6][7]. - Its main components (type I and type II alveolar cells) have individual molecular roles (e.g., sodium channels, surfactant proteins), but as a whole, the term represents a structural and functional collective rather than a discrete druggable molecule. - Drugs do not target the alveolar epithelium as a whole; treatments in pulmonary medicine often affect its function indirectly (e.g., steroids for inflammation, surfactant replacement in neonates), but these are not specific molecular interactions. - As it is not a specific molecular entity, entries for "interacting_drugs", "mechanism_of_action", and related pharmacological properties are not generally applicable[1][2][3][6]. Conclusion: This target name is imprecise and does not correspond to a canonical molecular target. For drug target data, you should seek specific molecular entities (for example: "Epithelial sodium channel," "Surfactant protein B," "ATP-binding cassette sub-family A member 3," etc.) within the pulmonary alveolar epithelium.

Other names
Alveolar epitheliumAlveolar epithelial layer
02

Biological functions

Gas exchangePhysical barrier (against pathogens/particles)Surfactant secretionFluid balanceTissue repair/regenerationImmune response
03

Disease associations

InfectionInflammationLung injuryPulmonary fibrosisAcute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on Pulmonary alveolar epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulmonary alveolar epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call